Loading…
Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort
Scheiner, Bernhard, Kirstein, Martha M., Hucke, Florian, Finkelmeier, Fabian, Schulze, Kornelius, von Felden, Johann, Koch, Sandra, Schwabl, Philipp, Hinrichs, Jan B., Waneck, Fredrik, Waidmann, Oliver, Reiberger, Thomas, Müller, Christian, Sieghart, Wolfgang, Trauner, Michael, Weinmann, Arndt, Wege, Henning, Trojan, Jörg, Peck‐Radosavljevic, Markus, Vogel, Arndt, Pinter, Matthias
Published in Alimentary pharmacology & therapeutics (01.05.2019)
Published in Alimentary pharmacology & therapeutics (01.05.2019)
Get full text
Journal Article
Loading…
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia‐Chi, Yoon, Jung‐Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu‐Yi, Kelley, Robin K., Brown, Joanne, Knox, Jennifer, Ryoo, Baek‐Yeol, Yau, Thomas, Abou‐Alfa, Ghassan K.
Published in The oncologist (Dayton, Ohio) (01.06.2019)
Published in The oncologist (Dayton, Ohio) (01.06.2019)
Get full text
Journal Article
Loading…
Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Feng, Fan, Jiang, Qiyu, Cao, Shuang, Cao, Yu, Li, Ruisheng, Shen, Lijun, Zhu, Hua, Wang, Tao, Sun, Lijun, Liang, Erguang, Sun, Huiwei, Chai, Yantao, Li, Xiaojuan, Liu, Genyan, Yang, Ruichang, Yang, Zhi, Yang, Yongping, Xin, Shaojie, Li, Bo-an
Published in Biochimica et biophysica acta. General subjects (01.04.2018)
Published in Biochimica et biophysica acta. General subjects (01.04.2018)
Get full text
Journal Article
Loading…
Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
Tamai, Toshiyuki, Hayato, Seiichi, Hojo, Seiichiro, Suzuki, Takuya, Okusaka, Takuji, Ikeda, Kenji, Kumada, Hiromitsu
Published in Journal of clinical pharmacology (01.09.2017)
Published in Journal of clinical pharmacology (01.09.2017)
Get full text
Journal Article
Loading…
Loading…
Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
Piñero, Federico, Marciano, Sebastián, Fernández, Nora, Silva, Jorge, Anders, Margarita, Zerega, Alina, Ridruejo, Ezequiel, Romero, Gustavo, Ameigeiras, Beatriz, D’Amico, Claudia, Gaite, Luis, Bermúdez, Carla, Reggiardo, Virginia, Colombato, Luis, Gadano, Adrián, Silva, Marcelo
Published in World journal of gastroenterology : WJG (21.07.2019)
Published in World journal of gastroenterology : WJG (21.07.2019)
Get full text
Journal Article
Loading…
A phase 1b/2, open-label study of tivozanib in combination with durvalumab in subjects with advanced hepatocellular carcinoma (Deductive)
Dayyani, Farshid, Lee, Arielle Shebay, Li, Daneng, Rowe, Julie Haewon, Beg, Muhammad Shaalan, Kasturi, Vijay, Iyer, Renuka V.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Loading…
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Yau, Thomas, Cheng, Paul N. M., Chiu, Joanne, Kwok, Gerry Gin Wai, Leung, Roland, Liu, Angela M., Cheung, Tan To, Ng, Chi Tao
Published in Investigational new drugs (01.04.2022)
Published in Investigational new drugs (01.04.2022)
Get full text
Journal Article
Loading…
Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study
Cheng, Ann-Lii, Kang, Yoon-Koo, He, Aiwu Ruth, Lim, Ho Yeong, Ryoo, Baek-Yeol, Hung, Chao-Hung, Sheen, I-Shyan, Izumi, Namiki, Austin, TaShara, Wang, Qiang, Greenberg, Jonathan, Shiratori, Shinichi, Beckman, Robert A., Kudo, Masatoshi
Published in Journal of hepatology (01.10.2015)
Published in Journal of hepatology (01.10.2015)
Get full text
Journal Article
Loading…
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification
Miyaki, Daisuke, Aikata, Hiroshi, Honda, Yohji, Naeshiro, Noriaki, Nakahara, Takashi, Tanaka, Mio, Nagaoki, Yuko, Kawaoka, Tomokazu, Takaki, Shintaro, Waki, Koji, Hiramatsu, Akira, Takahashi, Shoichi, Ishikawa, Masaki, Kakizawa, Hideaki, Awai, Kazuo, Chayama, Kazuaki
Published in Journal of gastroenterology and hepatology (01.12.2012)
Published in Journal of gastroenterology and hepatology (01.12.2012)
Get full text
Journal Article
Loading…
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy
Shi, Yaoping, Shi, Donghua, Chi, Jiachang, Cui, Dan, Tang, Xiaoyin, Lin, Yan, Wang, Siying, Li, Zonghai, Jin, Haojie, Zhai, Bo
Published in Cancer communications (London, England) (01.09.2023)
Published in Cancer communications (London, England) (01.09.2023)
Get full text
Journal Article
Loading…
Fibrinogen and D‐dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes
Liu, Zhikun, Guo, Haijun, Gao, Feng, Shan, Qiaonan, Li, Jie, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen
Published in Hepatology research (01.10.2017)
Published in Hepatology research (01.10.2017)
Get full text
Journal Article
Loading…
DEDUCTIVE: A study of tivozanib in combination with durvalumab in subjects with untreated advanced hepatocellular carcinoma—Phase Ib results
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Phan, Alexandria T., Needle, Michael N., Abrams, Thomas Adam
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Loading…
Phase 1b/2 study of tivozanib in combination with durvalumab in subjects with advanced hepatocellular carcinoma (Deductive): Efficacy results in previously untreated patients
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Rowe, Julie Haewon, Beg, Muhammad Shaalan, Kasturi, Vijay, Abrams, Thomas Adam
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Loading…
Comparison Between Neutrophil–Lymphocyte Ratio and Systemic Immune-Inflammation Index as Predictors of One-Year Survival in Patients with Untreated Advanced Hepatocellular Carcinoma
Hasan, Irsan, Lutfie, Lutfie, Rinaldi, Ikhwan, Kurniawan, Juferdy, Loho, Imelda Maria
Published in Journal of gastrointestinal cancer (01.03.2023)
Published in Journal of gastrointestinal cancer (01.03.2023)
Get full text
Journal Article
Loading…
A phase Ib/II, open-label study of tivozanib in combination with durvalumab in subjects with untreated advanced hepatocellular carcinoma
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Needle, Michael N., Abrams, Thomas Adam
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy
Chay, Wen Yee, Tham, Chee Kian, Toh, Han Chong, Lim, Hwee Yong, Tan, Chee Kiat, Lim, Cindy, Wang, Who-Whong, Choo, Su-Pin
Published in The journal of alternative and complementary medicine (New York, N.Y.) (01.08.2017)
Published in The journal of alternative and complementary medicine (New York, N.Y.) (01.08.2017)
Get more information
Journal Article
Loading…
Abstract 3171: Biomarkers of responses to immunotherapy in advanced hepatocellular carcinoma
Ting, Vox Z., Chew, Valerie, Wong, Carmen C., Yau, Thomas C.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Loading…
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment
Qin, S.K., Ren, Z.G., Meng, Z.Q., Chen, Z.D., Chai, X.L., Xiong, J.P., Bai, Y.X., Yang, L., Zhu, H., Fang, W.J., Lin, X.Y., Chen, X.M., Li, E.X., Xia, Y., Zou, J.J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article